-
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages
Source: Buzz FX / 04 Mar 2025 03:21:15 America/Chicago
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Collegium Pharmaceutical, Inc.
Read more...